21.2.2017

The Unified Patent System – Where Do We Stand Now?

Lately, there has been a lot of discussion around the UPC and European patents with unitary effect. But what is the UPC and what does it mean in practice? What are European patents with unitary effect and how do they differentiate from the traditional European patents?

Towards an Enhanced European Patent System

First of all, the UPC relates to the European-wide patent reform. The UPC, which is an abbreviation for the Unified Patent Court, is a planned single patent court covering 25 EU member states. If established, the UPC would be a common court to all member states contracting to the Unified Patent Court Agreement.

The purpose is that the UPC would have exclusive jurisdiction over both future European patents with unitary effect, European patents validated in one or more EU member state which is a party to the Unified Patent Court Agreement, supplementary protection certificates issued for a product covered by such a patent and European patent applications − the jurisdiction, however, being subject to certain exceptions during the transitional period. The UPC’s rulings would have effect in those contracting member states that have ratified the Unified Patent Court Agreement. The UPC would not have any jurisdiction over national patents or supplementary protection certificates granted for a national patent. After the reform, the Finnish Market Court would still have jurisdiction over Finnish national patents and supplementary protection certificates granted for a Finnish patent.

The European patent with unitary effect − the unitary patent − would be a new, supranational option to have patent protection in Europe. At the moment a European patent needs to be validated in each contracting state where patent protection is desired. This means in practice that a patent holder has a bundle of national patents. A unitary patent would only consist of a one single patent providing patent protection in the member states who are participating in the enhanced cooperation procedure.

After the reform, unitary patents and traditional European patents will be granted by European Patent Office (EPO). The pre-grant phase at the EPO is not subject to change. When the EPO has granted a European patent, the patent holder can file a request for unitary effect, i.e., a uniform patent protection in the participating member states.    

When Will All This Happen?

To date, the implementation of the unified patent system is still ongoing. In order for the entire system to come into force, the Unified Patent Court Agreement must be ratified by at least thirteen EU member states (including the high-profile patent countries: the UK, France and Germany). At the moment, the following member states have ratified the agreement: Austria, Belgium, Bulgaria, Denmark, Finland, France, Italy, Luxembourg, Malta, Netherlands, Portugal and Sweden. Last autumn, the UK government confirmed it is continuing with preparations for ratification of the Unified Patent Court Agreement despite Brexit.

According to the latest information, the UPC Preparatory Committee, which is an entity responsible for establishment of the UPC, is currently working under the assumption that the Provisional Application Phase (PAP) will start this spring, most likely in May 2017. In practice, the PAP means that the UPC organisation will be established.

The assumption is that the Unified Patent Court Agreement will enter into force and the UPC will become operational in December of this year. Before the UPC becomes operational, the patent holders or applicants have the possibility to opt out their already-existing European patents or patent applications from the new UPC system for the whole life-time of that patent. This sunrise period for opting out patents will be a minimum of 3 months. The current plan is that the opt-out period will start in September 2017. As the sunrise period is somewhat short, it is worth making some contingency plans in this regard and considering implementing the opt-out (if so desired) already in the beginning of the sunrise period in order have sufficient time to deal with any possible queries or difficulties in the opt-out registration procedure.

Latest references

We are acting as legal advisor to Piippo Plc in the sale of their bale netwrap and baler twine machines, related assets, and trademarks used in Piippo’s business to Portuguese Cotesi S.A. The sale of assets will be carried out in two phases and the final completion of the transaction is expected to occur during the first quarter of 2026. Piippo Oyj’s core business is baling nets and twine and it is one of the leading suppliers in the industry globally. The company’s global distribution network covers more than 40 countries. The company’s shares are listed on the First North Growth Market Finland operated by Nasdaq Helsinki Oy. Founded in 1967, Cotesi is one of the world’s leading producers of synthetic and natural twines, nets and ropes, with operations in Europe, North America and South America and its main production plant in Vila Nova de Gaia, Portugal.
Case published 17.4.2025
We acted as Finnish legal adviser to KKR in connection with its acquisition of the entire share capital of Karo Healthcare from EQT. The transaction follows Karo’s significant strategic transformation from a Nordic specialty pharma business into a leading pan-European consumer healthcare platform, with an attractive product portfolio spanning core categories such as Skin Health, Foot Health, and Intimate Health, as well as Digestive Health and Vitamins, Minerals & Supplements. KKR & Co. Inc. (NYSE: KKR), is a leading global investment firm that offers alternative asset management as well as capital markets and insurance solutions. KKR sponsors investment funds that invest in private equity, credit and real assets and has strategic partners that manage hedge funds.  Completion of the transaction is subject to customary conditions and regulatory approvals. The transaction is expected to close in the coming months.
Case published 17.4.2025
We advised the Savings Banks Group on an arrangement whereby the shares in Sp-Henkivakuutus Oy were sold to Henki-Fennia and at the same time the parties agreed on a long-term distribution cooperation for insurance savings and loan protection products. The closing of the transaction remains subject to regulatory approvals. Sb Life Insurance is a domestic life insurance company, established in 2007, offering insurance savings and risk insurance products to private customers and companies. The Savings Banks and Oma Säästöpankki Oyj act as agents for Sp-Life Insurance. Henki-Fennia is a subsidiary of Keskinäinen Vakuutusyhtiö Fennia, specialising in voluntary life, pension and savings insurance.
Case published 11.4.2025
We advised Readpeak in an arrangement where Finnish growth fund Voland Partners made an investment in Readpeak. Readpeak is a service platform specialising in native advertising for purchasing, designing, and targeting the distribution of advertising space. Readpeak has quickly risen to a leading position with its platform solution, which enables an easy way to target and schedule communications as part of the news feed on media sites. Readpeak is a company founded in Helsinki in 2014, which has since expanded to nine European market areas and collaborates with over a thousand publishers. Readpeak redefines content-driven advertising using advanced machine learning models, creating added value for both quality media and journalism. Voland Partners is a minority investor specialising in the development of technology companies, with a mission to work together with entrepreneurs to build successful companies responsibly, creating success stories that benefit the entire society. Readpeak is Voland Partners’ sixth investment target, into which the fund company is investing from its first growth fund of 57 million euros.
Case published 10.4.2025